scholarly journals Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk

2002 ◽  
Vol 186 (8) ◽  
pp. 1173-1176 ◽  
Author(s):  
Carey Farquhar ◽  
Thomas C. VanCott ◽  
Dorothy A. Mbori‐Ngacha ◽  
Lena Horani ◽  
Rose K. Bosire ◽  
...  
1996 ◽  
Vol 29 (2-3) ◽  
pp. 269-277 ◽  
Author(s):  
Jim A. Turpin ◽  
Catherine A. Schaeffer ◽  
Ming Bu ◽  
Lisa Graham ◽  
Robert W. Buckheit ◽  
...  

2000 ◽  
Vol 7 (3) ◽  
pp. 515-518 ◽  
Author(s):  
Hakim Hocini ◽  
Pierre Becquart ◽  
Hicham Bouhlal ◽  
Homa Adle-Biassette ◽  
Michel D. Kazatchkine ◽  
...  

ABSTRACT In the present study, we demonstrate that recombinant human secretory leukocyte protease inhibitor (rhSLPI) inhibits infection of lymphocyte- and monocyte-derived tumor cell lines and peripheral blood lymphocytes with laboratory-adapted isolates and with the primary isolate, NDK, of free human immunodeficiency virus type 1 (HIV-1). In contrast, rhSLPI did not exhibit inhibitory activity toward transcytosis of cell-associated HIV-1 through a tight monolayer of endometrial epithelial cells. These observations indicate that the inhibitory effect of SLPI is restricted to free HIV-1 in corporal fluids.


2001 ◽  
Vol 183 (4) ◽  
pp. 653-656 ◽  
Author(s):  
Kubendran Pillay ◽  
Anna Coutsoudis ◽  
Anthony K. Agadzi‐Naqvi ◽  
Louise Kuhn ◽  
Hoosen M. Coovadia ◽  
...  

2003 ◽  
Vol 41 (6) ◽  
pp. 2465-2470 ◽  
Author(s):  
M. K. Ghosh ◽  
L. Kuhn ◽  
J. West ◽  
K. Semrau ◽  
D. Decker ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document